Adrenaline

Veta™ Smart Case & App for epinephrine auto-injectors (such as EPIPEN®) now available in Walgreens

Retrieved on: 
Dienstag, September 3, 2019
Medical specialties, Medicine, RTT, Immunology, Respiratory diseases, Allergology, Immune system, Food allergy, Aterica, Allergy, Anaphylaxis, Adrenaline

WATERLOO, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Aterica Digital Health today announces the Walgreens in-store availability of Veta Smart Case & App the first-ever comprehensive anaphylaxis and food allergy support system for individuals and their families.

Key Points: 
  • WATERLOO, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Aterica Digital Health today announces the Walgreens in-store availability of Veta Smart Case & App the first-ever comprehensive anaphylaxis and food allergy support system for individuals and their families.
  • Veta provides peace of mind for everyone involved by surrounding individuals with a connected support circle of family, friends, and caregivers using Veta App and a network of sensor-filled Veta Smart Case-enabled epinephrine auto-injectors.
  • Keeping life-saving epinephrine with you when you need it is paramount for those with life-threatening anaphylaxis, said Alex Leyn, CEO of Aterica.
  • This expanded consumer access to Veta Smart Cases demonstrates our commitment to offering an advanced patient-friendly solution that eases the challenges of daily vigilance and offers greater independence.

Veta™ Smart Case & App for epinephrine auto-injectors (such as EPIPEN®) now available in Walgreens

Retrieved on: 
Freitag, August 30, 2019
Medical specialties, Medicine, RTT, Immunology, Respiratory diseases, Allergology, Immune system, Food allergy, Aterica, Allergy, Anaphylaxis, Adrenaline

WATERLOO, Ontario, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Aterica Digital Health today announces the Walgreens in-store availability of Veta Smart Case & App the first-ever comprehensive anaphylaxis and food allergy support system for individuals and their families.

Key Points: 
  • WATERLOO, Ontario, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Aterica Digital Health today announces the Walgreens in-store availability of Veta Smart Case & App the first-ever comprehensive anaphylaxis and food allergy support system for individuals and their families.
  • Veta provides peace of mind for everyone involved by surrounding individuals with a connected support circle of family, friends, and caregivers using Veta App and a network of sensor-filled Veta Smart Case-enabled epinephrine auto-injectors.
  • Keeping life-saving epinephrine with you when you need it is paramount for those with life-threatening anaphylaxis, said Alex Leyn, CEO of Aterica.
  • This expanded consumer access to Veta Smart Cases demonstrates our commitment to offering an advanced patient-friendly solution that eases the challenges of daily vigilance and offers greater independence.

Serial Beverage Entrepreneur Lance Collins Launches Adrenaline Shoc

Retrieved on: 
Mittwoch, April 17, 2019
Drinks, Energy drinks, Hormones, Branches of biology, Nós, Fuze Beverage, Southern Hemisphere Ornithological Congress, Adrenaline

BEVERLY HILLS, Calif., April 17, 2019 /PRNewswire/ -- Lance Collins, successful beverage industry entrepreneur and founder of iconic brands such as Fuze, NOS Energy, and CORE, is launching Adrenaline Shoc (A Shoc), a modern "smart energy" drink designed for today's active generation.

Key Points: 
  • BEVERLY HILLS, Calif., April 17, 2019 /PRNewswire/ -- Lance Collins, successful beverage industry entrepreneur and founder of iconic brands such as Fuze, NOS Energy, and CORE, is launching Adrenaline Shoc (A Shoc), a modern "smart energy" drink designed for today's active generation.
  • Speaking on his newest beverage launch, Lance shared, "We are extremely focused on Adrenaline Shoc's unique positioning in the market, with emphasis on the active fitness enthusiast andthegrowing consumer demand for healthier and more functional alternatives to traditional energy drinks.
  • We're placing A Shoc in traditional Energy doorsas well as new Fitness Enhanced Energy spacethatretailers havecreated to helptarget consumerslooking topurchaseperformance energydrinks.
  • Rodger Collins, KDP President of Direct Store Delivery, added, "We have partnered successfully with Lance in the past, most recently on CORE Hydration, and are excited to do so again on A Shoc.

Humm.ly, the First Music-Therapy App, Now Allows Users to Monitor their Heart Rate in Real Time

Retrieved on: 
Mittwoch, April 10, 2019
Entertainment, Music, Technology, Software, Health, Alternative medicine, Cardiology, Branches of biology, Stress, Organ systems, Anxiety, Sympathetic nervous system, Adrenaline, Catecholamines, Neurotransmitters, Cortisol, Hormone, Psychological stress, Maternal fetal stress transfer

The technique isnt limited to just one's mood; it also has physiological benefits known to have a positive response on heart rate and blood pressure.

Key Points: 
  • The technique isnt limited to just one's mood; it also has physiological benefits known to have a positive response on heart rate and blood pressure.
  • In the latest update, the app now will feature a heart rate reader so you can see in real-time the benefits.
  • Cortisol and adrenaline (two stress hormones) levels are elevated which in turn increases the heart rate, blood pressure, and respiratory rate.
  • With the Humm.ly latest update, users now can observe how the heart is reacting to the music through its real-time heart rate tracking feature in the app.

ARS Pharmaceuticals Announces FDA Fast Track Designation for ARS-1 Intranasal Epinephrine Spray

Retrieved on: 
Dienstag, Februar 19, 2019
Health, Biotechnology, Hospitals, Pharmaceutical, FDA, Medical Supplies, Drugs, Medicine, Clinical medicine, RTT, Alcohols, Respiratory therapy, Glucocorticoids, Epinephrine, Nasal administration, Injection, Medroxyprogesterone acetate, Adrenaline

Fast Track Designation is an acknowledgement from the FDA of the potential contribution of our low dose intranasal epinephrine product for patients and caregivers, and we look forward to advancing the development of ARS-1 so it is available to the community as soon as possible.

Key Points: 
  • Fast Track Designation is an acknowledgement from the FDA of the potential contribution of our low dose intranasal epinephrine product for patients and caregivers, and we look forward to advancing the development of ARS-1 so it is available to the community as soon as possible.
  • ARS-1 is an aqueous formulation of epinephrine nasal spray uniquely developed with Intravail, a novel nasal absorption enhancing technology.
  • ARS-1 has demonstrated comparable pharmacokinetics to an intramuscular injection of epinephrine in clinical studies using a low and safe intranasal dose.
  • The intranasal epinephrine spray is also designed to be user-friendly, needle-free and easily portable to carry in a pocket or purse anytime, anywhere.

Riding A Motorcycle Improved Metrics Of Focus And Decreased Stress Biomarkers, According To A New Neurobiological Study

Retrieved on: 
Donnerstag, Januar 17, 2019
Stress, Anxiety, Endocrine system, Biology, Neuroscience, Sympathetic nervous system, Cortisol, Otologicals, Pregnanes, Psychological stress, Adrenaline, Hormone

Funded by Harley-Davidson, the study found that motorcycling increasedmetrics of focus and attention, and decreased relative levels of cortisol, a hormonal marker of stress.

Key Points: 
  • Funded by Harley-Davidson, the study found that motorcycling increasedmetrics of focus and attention, and decreased relative levels of cortisol, a hormonal marker of stress.
  • Riding also produced an increase in adrenaline levelsand heart rate, as well as a decrease in cortisol metrics resultsoften associated with light exercise and stress-reduction.
  • "The differences in participants' neurological and physiological responses between riding and other measured activities were quite pronounced," continued Dr. Vaughn.
  • For those who wish to experience the heightened sensory experience of riding first-hand, H-D Riding Academy will introduce you to motorcycle riding and build your skills in just a few days, regardless of experience level.

End Allergies Together Launches A Public Service Announcement "Give and Go" To Promote Action When Anaphylactic Reactions Occur

Retrieved on: 
Donnerstag, August 23, 2018
Medicine, Immunology, Clinical medicine, RTT, Allergology, Respiratory diseases, Medical emergencies, Food allergy, Allergy, Epinephrine, Anaphylaxis, Adrenaline

Every two to three minutes someone goes to the emergency room due to a food allergy-induced, life-threatening anaphylactic reaction2.

Key Points: 
  • Every two to three minutes someone goes to the emergency room due to a food allergy-induced, life-threatening anaphylactic reaction2.
  • This is especially troubling given the fact that fatal anaphylaxis has been associated with delayed administration of epinephrine.
  • "Just like there is 'Stop, Drop and Roll' for fire safety, we need clear action for anaphylactic reactions.
  • EAT's PSA is an important educational tool for learning that epinephrine is the first response to life threatening allergic reactions."

FDA approves first generic version of EpiPen

Retrieved on: 
Donnerstag, August 16, 2018
Medicine, Health, Type I hypersensitivity, Epinephrine, Epinephrine autoinjector, First aid, Autoinjector, Anaphylaxis, Generic drug, Adrenaline, Teva Pharmaceutical Industries, Food and Drug Administration

Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.

Key Points: 
  • Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.
  • We're advancing new guidance for sponsors to make the development of generic versions of complex products more efficient, and we're prioritizing review of many complex generic drug applications."
  • The FDA has approved several epinephrine auto-injector products under new drug applications to treat anaphylaxis, including EpiPen, Adrenaclick and Auvi-Q.
  • In this case, the FDA has published three draft or final guidances since 2009 related to the development of generic epinephrine auto-injectors.